ACHIEVEMENT OF PROPHYLACTIC ANTI-XA LEVELS IN TRAUMA PATIENTS RECEIVING ENOXAPARIN

被引：0
|
作者：
Meadows, Evan [1 ]
Partlow, Karen [1 ]
Rubertus, Matthew [2 ]
Quick, Valerie [1 ]
Davis, John [1 ]
Flannagan, Molly [1 ]
Griffin, Mary Lewis [1 ]
机构：
[1] UVA Hlth, Charlottesville, VA USA
[2] UVA Hlth, Atlanta, GA USA
来源：
CRITICAL CARE MEDICINE | 2024年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
1594
引用
收藏
页数：1
相关论文
共 50 条
  • [41] QUASIEXPERIMENTAL EVALUATION OF A WEIGHT-TIERED, ANTI-XA ENOXAPARIN PROPHYLAXIS PROTOCOL IN TRAUMA
    Deichstetter, Kaley
    Farrar, Julie
    Philpott, Carolyn
    Droege, Christopher
    Ernst, Neil
    Mueller, Eric
    Katampe, Stephanie
    O'Toole, Erin
    Roell, Claire
    Makley, Amy
    Sagi, Henry
    Droege, Molly
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 782 - 782
  • [42] Impact of antithrombin III and enoxaparin dosage adjustment on prophylactic anti-Xa concentrations in trauma patients at high risk for venous thromboembolism: a randomized pilot trial
    Molly Elizabeth Droege
    Christopher Allen Droege
    Carolyn Dosen Philpott
    Megan Leslie Webb
    Neil Edward Ernst
    Krishna Athota
    Devin Wakefield
    Joseph Richard Dowd
    Dina Gomaa
    Bryce H. R. Robinson
    Dennis Hanseman
    Joel Elterman
    Eric William Mueller
    Journal of Thrombosis and Thrombolysis, 2021, 52 : 1117 - 1128
  • [43] Impact of antithrombin III and enoxaparin dosage adjustment on prophylactic anti-Xa concentrations in trauma patients at high risk for venous thromboembolism: a randomized pilot trial
    Droege, Molly Elizabeth
    Droege, Christopher Allen
    Philpott, Carolyn Dosen
    Webb, Megan Leslie
    Ernst, Neil Edward
    Athota, Krishna
    Wakefield, Devin
    Dowd, Joseph Richard
    Gomaa, Dina
    Robinson, Bryce H. R.
    Hanseman, Dennis
    Elterman, Joel
    Mueller, Eric William
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 52 (04) : 1117 - 1128
  • [44] Factor Xa Levels in Patients receiving Prophylactic Enoxaparin Sodium in the Intensive Care Unit of an Academic Hospital
    Baloo, Mayank M.
    Scribante, Juan
    Perrie, Helen
    Calleemalay, Daren
    Omar, Shahed
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2021, 25 (08) : 918 - 920
  • [45] Anti-Xa stability of diluted enoxaparin for use in pediatrics
    Dager, WE
    Gosselin, RC
    King, JH
    Christensen, CL
    Owings, JT
    Larkin, EC
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (04) : 569 - 573
  • [46] Comparison of Anti-Xa Activity in Patients Receiving Apixaban or Rivaroxaban
    Bookstaver, David A.
    Sparks, Kimberly
    Pybus, Brandon S.
    Davis, Dustin K.
    Marcsisin, Sean R.
    Sousa, Jason C.
    ANNALS OF PHARMACOTHERAPY, 2018, 52 (03) : 251 - 256
  • [47] The effect of the topical anaesthetic maxilene on enoxaparin metabolism as measured by peak anti-XA levels
    Bauman, M. E.
    Duncan, S.
    Ray, L.
    Bajzar, L.
    Kuhle, S.
    Massicotte, M. P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 778 - 778
  • [48] Enoxaparin dosing in advanced chronic kidney disease: importance of monitoring with anti-Xa levels
    Cases Corona, Clara Maria
    Lopez Melero, Eva
    Landaluce Triska, Eugenia
    Leon, Mariana
    Roldan, Deborah
    Gruss, Enrique
    Shabaka, Amir
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2323 - I2323
  • [49] Observed Apixaban Anti-Xa Levels in Obese Patients
    Harkness, Weston
    Pipitone, Olivia
    Joss, Jacqueline
    Schiedler, Michael
    Shagavah, Santon
    Moore, Ryan
    Hsing, Jeff
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (11) : 1215 - 1221
  • [50] ANTI-XA MONITORING OF THERAPEUTIC ENOXAPARIN IN PATIENTS WEIGHING AT LEAST 90 KILOGRAMS
    Hur, Mina
    Kim, Hanah
    Park, Mikyoung
    Chung, Hee-Jung
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E26 - E27
12345